ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith, the intimation dated 29th February, 2024 received from RTA.29-02-2024
29-02-2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith, the intimation dated 26th February, 2024 received from Link Intime India Private Limited, RTA, regarding lost/misplaced share certificate(s) of the Company.26-02-2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
The Company has now fully resumed its manufacturing operations at Sikkim Plant.23-02-2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith the Intimation of Loss of Share Certificate dated 16th February, 2024 received from Link Intime Private Limited.16-02-2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that the management of the Company shall be meeting analysts/investors through Investors Conference hosted by Kotak Securities Limited on 19th February, 2024 in Mumbai.13-02-2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith, Intimation for Issue of Duplicate Share Certificate dated 12th February, 2024 received from Link Intime India Private Limited.12-02-2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the Earnings Call held on 5th February, 202409-02-2024
Alembic Pharmaceuticals Q3 FY24 Results Live: Profit Rises by 48.25% YoY
Alembic Pharmaceuticals Q3 FY24 Results Live: Revenue increased by 8.05% YoY & profit increased by 48.25% YoY07-02-2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached herewith the Newspaper Publication dated 6th February, 2024.06-02-2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
With reference to the captioned subject, this is to inform the exchange that the audio recording has been hosted on the website of the Company and can be accessed at https://alembicpharmaceuticals.com/quarterly-results/05-02-2024